Russell Investments Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
38,179
+21,724
+132% +$1.18M ﹤0.01% 1829
2025
Q4
$759K Sell
16,455
-517
-3% -$23.1K ﹤0.01% 2341
2025
Q3
$611K Sell
16,972
-12,420
-42% -$411K ﹤0.01% 2396
2025
Q2
$956K Sell
29,392
-170,198
-85% -$5.58M ﹤0.01% 2084
2025
Q1
$7.54M Buy
199,590
+91,201
+84% +$7.29M 0.01% 946
2024
Q4
$8.87M Buy
108,389
+29,442
+37% +$2.92M 0.01% 866
2024
Q3
$9.02M Buy
78,947
+59,988
+316% +$5.41M 0.01% 879
2024
Q2
$1.43M Buy
18,959
+101
+0.5% +$6.88K ﹤0.01% 1806
2024
Q1
$1.29M Buy
+18,858
New +$1.31M ﹤0.01% 1876
2023
Q3
Sell
-805
Closed -$40.2K 3601
2023
Q2
$40.2K Hold
805
﹤0.01% 2750
2023
Q1
$30.2K Buy
+805
New +$34.1K ﹤0.01% 2771
2021
Q1
Sell
-22,229
Closed -$590K 3177
2020
Q4
$590K Buy
+22,229
New +$826K ﹤0.01% 2359

Other funds holding PCVX